Results

Total Results: over 10,000 records

Showing results for "discussed".

  1. A_ReferenceLibrary (pdf file)

    digital.ahrq.gov/sites/default/files/docs/page/A_ReferenceLibrary_1.pdf
    February 16, 2006 - The publication is intended as an aid to understanding security concepts discussed in the HIPAA Security
  2. digital.ahrq.gov/sites/default/files/docs/survey/qualitative-interview-ehr-implementation.pdf
    June 16, 2021 - What incentives have been discussed or are being planned for staff for implementation? 11.
  3. effectivehealthcare.ahrq.gov/sites/default/files/ch_9-user-guide-to-ocer_130129.pdf
    September 21, 2012 - number of recruited patients available for analysis (e.g., due to loss to followup) should also be discussed
  4. psnet.ahrq.gov/web-mm/discontinued-medications-are-they-really-discontinued
    January 05, 2017 - In the current case, if the discontinuation of warfarin had been discussed with the patient in detail
  5. psnet.ahrq.gov/web-mm/surgical-personality-threat-patient-safety
    February 24, 2021 - has a financial arrangement or other relationship with the manufacturers of any commercial products discussed
  6. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/49630/psn-pdf
    July 01, 2011 - have a financial arrangement or other relationship with the manufacturers of any commercial products discussed
  7. meps.ahrq.gov/data_files/publications/st464/stat464.shtml
    December 01, 2014 - All differences between estimates discussed in the text are statistically significant at the 0.05 level
  8. meps.ahrq.gov/data_files/publications/st87/stat87.shtml
    July 01, 2005 - All differences between estimates discussed in the text are statistically significant at the 0.05 level
  9. psnet.ahrq.gov/web-mm/cvc-removal-procedure-any-other
    October 01, 2018 - embolism formation, CVC removal carries other risks such as bleeding, catheter fracture, and embolism (discussed
  10. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/49869/psn-pdf
    July 02, 2019 - The scan results were discussed by the patient's obstetrician, the obstetrics and gynecology department
  11. psnet.ahrq.gov/web-mm/reconciling-doses
    August 14, 2017 - has a financial arrangement or other relationship with the manufacturers of any commercial products discussed
  12. psnet.ahrq.gov/web-mm/primary-workaround-secondary-complication
    January 24, 2018 - This is easier when the workarounds, such as the Foley catheter, are sanctioned and can be openly discussed
  13. www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/mrsa/062-protocol-training-decolonization-with-chg.pptx
    October 01, 2024 - Multiple methods of CHG bathing are discussed in these slides, including: Bed bathing with 2% CHG impregnated
  14. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/49663/psn-pdf
    September 01, 2012 - has a financial arrangement nor other relationship with the manufacturers of any commercial products discussed
  15. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/49804/psn-pdf
    September 01, 2017 - have a financial arrangement or other relationship with the manufacturers of any commercial products discussed
  16. psnet.ahrq.gov/web-mm/potent-medication-administered-not-so-viable-route
    July 20, 2016 - The case was discussed in the multi-departmental morbidity and mortality review, and a new protocol was
  17. psnet.ahrq.gov/web-mm/lost-sign-out-and-documentation
    January 31, 2011 - The patient had no abdominal symptoms, and the CCU team discussed the case with a gastroenterologist
  18. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/49440/psn-pdf
    March 01, 2004 - importance of confirmation bias and other cognitive pitfalls that affect diagnostic reasoning have been discussed
  19. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/49498/psn-pdf
    January 01, 2006 - has a financial arrangement or other relationship with the manufacturers of any commercial products discussed
  20. www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/mvp/modules/cusp/build-businesscase-facguide.docx
    January 01, 2017 - Earlier we discussed an intervention that reduced ICU length of stay or LOS by 3 days.